The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy
Open accessAbstract
The selection of bacterial resistance was examined in relationship to antibiotic pharmacokinetics (PK) and organism MICs in the patients from four nosocomial lower respiratory tract infection clinical trials. The evaluable database included 107 acutely ill patients, 128 pathogens, and five antimicrobial regimens. Antimicrobial pharmacokinetics were characterized by using serum concentrations, and culture and sensitivity tests were performed daily on tracheal aspirates to examine resistance. Pharmacodynamic (PD) models were developed to identify factors associated with the probability of developing bacterial resistance. Overall, in 32 of 128 (25%) initially susceptible cases resistance developed during therapy. An initial univariate screen and a classification and regression tree analysis identified the ratio of the area under the concentration-time curve from 0 to 24 h to the MIC (AUC 0–24/MIC) as a significant predictor of the development of resistance (P< 0.001). The final PK/PD model, a variant of the Hill equation, demonstrated that the probability of developing resistance during therapy increased significantly when antimicrobial exposure was at an AUC 0–24/MIC ratio of less than 100. This relationship was observed across all treatments and within all organism groupings, with the exception of β-lactamase-producing gram-negative organisms (consistent with type I β-lactamase producers) treated with β-lactam monotherapy. Combination therapy resulted in much lower rates of resistance than monotherapy, probably because all of the combination regimens examined had an AUC 0–24/MIC ratio in excess of 100. In summary, the selection of antimicrobial resistance appears to be strongly associated with suboptimal antimicrobial exposure, defined as an AUC 0–24/MIC ratio of less than 100.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
Forrest, A., Nix, D. E., Ballow, C. H., Goss, T. F., Birmingham, M. C., & Schentag, J. J. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.1073 · Cited by 1,101
Self-citationGold, H. S., & Moellering, R. C. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351907 · Cited by 1,070
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S., & Craig, W. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.831 · Cited by 720
A Bayesian extension of the minimum AIC procedure of autoregressive model fitting
AKAIKE, H. (1979) · Biometrika · doi:10.1093/biomet/66.2.237 · Cited by 629
Evolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
A program package for simulation and parameter estimation in pharmacokinetic systems
D'argenio, D. Z., & Schumitzky, A. (1979) · Computer Programs in Biomedicine · doi:10.1016/0010-468x(79)90025-4 · Cited by 471
Fink, M. P., Snydman, D. R., Niederman, M. S., Leeper, K. V., Johnson, R. H., Heard, S. O., Wunderink, R. G., Caldwell, J. W., Schentag, J. J., & Siami, G. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.547 · Cited by 461
Self-citationPharmacokinetics and pharmacodynamics of antibiotics in otitis media
CRAIG, W. A., & ANDES, D. (1996) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199603000-00015 · Cited by 435
Drusano, G. L., Johnson, D. E., Rosen, M., & Standiford, H. C. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.483 · Cited by 426
Hyatt, J. M., McKinnon, P. S., Zimmer, G. S., & Schentag, J. J. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199528020-00005 · Cited by 374
Self-citationFish, D. N., Piscitelli, S. C., & Danziger, L. H. (1995) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04366.x · Cited by 178
Peloquin, C. A. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390100083020 · Cited by 167
Madaras‐Kelly, K., Ostergaard, B. E., Hovde, L. B., & Rotschafer, J. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.627 · Cited by 161
Schentag, J. J., Nix, D. E., & Adelman, M. H. (1991) · DICP · doi:10.1177/106002809102501003 · Cited by 141
Self-citationRole for Dual Individualization with Cefmenoxime
Schentag, J. J., Smith, I. L., Swanson, D. J., DeAngelis, C., Fracasso, J. E., Vari, A., & Vance, J. W. (1984) · The American Journal of Medicine · doi:10.1016/s0002-9343(84)80074-1 · Cited by 129
Self-citationGoss, T. F., Forrest, A., Nix, D. E., Ballow, C. H., Birmingham, M. C., Cumbo, T. J., & Schentag, J. J. (1994) · Annals of Pharmacotherapy · doi:10.1177/106002809402800707 · Cited by 59
Self-citationAntibiotic Resistance: A View from the Pharmaceutical Industry
Bax, R. P. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s151 · Cited by 54
AUIC — The Universal Parameter within the Constraint of a Reasonable Dosing Interval
Schentag, J. J., Nix, D. E., Forrest, A., & Adelman, M. H. (1996) · Annals of Pharmacotherapy · doi:10.1177/106002809603000920 · Cited by 48
Self-citation
Cited by
Pharmacokinetic issues for antibiotics in the critically ill patient
Roberts, J. A., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181961bff · Cited by 862
Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785
Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium
Mesaros, N., Nordmann, P., Plésiat, P., Roussel-Delvallez, M., Van Eldere, J., Glupczynski, Y., Van Laethem, Y., Jacobs, F., Lebecque, P., Malfroot, A., et al. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01681.x · Cited by 585
Self-medication with Antimicrobial Drugs in Europe
Grigoryan, L., Haaijer-Ruskamp, F. M., Burgerhof, J. G. M., Mechtler, R., Deschepper, R., Tambic-Andrasevic, A., Andrajati, R., Monnet, D. L., Cunney, R., Di Matteo, A., et al. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1203.050992 · Cited by 585
Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention
Koenig, S. M., & Truwit, J. D. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-05 · Cited by 539
Metadata
- Authors
- Thomas, J. K., Forrest, A., Bhavnani, S. M., Hyatt, J. M., Cheng, A., Ballow, C. H., & Schentag, J. J.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1998-03
- Volume
- 42
- Issue
- 3
- Pages
- 521-527
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2138984944
- Cited by
- 507
- References
- 20
- FWCI
- 20.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.